Henry Schein, Inc. (NASDAQ:HSIC) CEO Bradford C. Connett Sells 4,036 Shares

Henry Schein, Inc. (NASDAQ:HSIC) CEO Bradford C. Connett sold 4,036 shares of the firm’s stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Henry Schein Stock Down 0.6 %

Shares of NASDAQ:HSIC opened at $70.45 on Friday. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.49. The stock has a 50-day simple moving average of $74.83 and a 200-day simple moving average of $72.61. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The stock has a market capitalization of $8.75 billion, a P/E ratio of 28.99, a PEG ratio of 2.13 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same quarter in the prior year, the company posted $0.66 earnings per share. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. Equities analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Institutional Trading of Henry Schein

Large investors have recently bought and sold shares of the company. Wealth Enhancement Advisory Services LLC boosted its stake in shares of Henry Schein by 34.0% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 52,891 shares of the company’s stock valued at $3,660,000 after purchasing an additional 13,431 shares during the period. Siemens Fonds Invest GmbH grew its stake in shares of Henry Schein by 282.3% during the fourth quarter. Siemens Fonds Invest GmbH now owns 13,366 shares of the company’s stock valued at $925,000 after acquiring an additional 9,870 shares in the last quarter. Menard Financial Group LLC purchased a new stake in shares of Henry Schein during the fourth quarter worth about $92,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Henry Schein in the fourth quarter worth about $5,743,000. Finally, Jefferies Financial Group Inc. boosted its holdings in Henry Schein by 98.8% in the fourth quarter. Jefferies Financial Group Inc. now owns 83,100 shares of the company’s stock valued at $5,751,000 after purchasing an additional 41,300 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analyst Upgrades and Downgrades

HSIC has been the topic of a number of research analyst reports. Jefferies Financial Group boosted their target price on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Barrington Research restated an “outperform” rating and set a $90.00 target price on shares of Henry Schein in a report on Wednesday, February 26th. Mizuho initiated coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target on the stock. UBS Group cut their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, February 26th. Finally, Wells Fargo & Company initiated coverage on Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price on the stock. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Henry Schein presently has an average rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.